Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Bendamustine Versus Fludarabine and Cyclophosphamide for Lymphodepletion Prior to CAR-T Therapy

Blood (2023) 142 (Supplement 1): 3504.

https://doi.org/10.1182/blood-2023-190388

Published: 2023

Journal Articles

Reduced Insulin Sensitivity in Patients with Myeloid Malignancies and Clonal Hematopoiesis Mutations

Uttam K. Rao, MD MBA, Heidi Chen, PhD, Katie S. Gatwood, PharmD, Michael T. Byrne, DO, Salyka M. Sengsayadeth, MD, Stacey A. Goodman, MD, Bhagirathbhai Dholaria, MBBS, Adetola A. Kassim, MDMS, Bipin N. Savani, MD, Wichai Chinratanalab, MD, Kathryn A. Culos, PharmD, Michael R. Savona, MD, Brian G. Engelhardt, MD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-137712

Published: 2020

Journal Articles

Nrf2 regulates CD4 + T cell–induced acute graft-versus-host disease in mice

Blood (2018) 132 (26): 2763–2774.

https://doi.org/10.1182/blood-2017-10-812941

Published: 2018

Includes: Supplemental data

Journal Articles

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL

Alan M. Hanash, Lucy W. Kappel, Nury L. Yim, Rebecca A. Nejat, Gabrielle L. Goldberg, Odette M. Smith, Uttam K. Rao, Lindsay Dykstra, Il-Kang Na, Amanda M. Holland, Jarrod A. Dudakov, Chen Liu, George F. Murphy, Warren J. Leonard, Glenn Heller, Marcel R. M. van den Brink

Blood (2011) 118 (2): 446–455.

https://doi.org/10.1182/blood-2010-07-294785

Published: 2011

Includes: Supplemental data

Journal Articles

Abrogation of Donor T Cell IL-21 Signaling Leads to Tissue-Specific Modulation of Immunity and Separation of Gvhd From GVL

Alan M. Hanash, MD, PhD, Lucy W. Kappel, Nury L. Yim, Rebecca A. Nejat, Gabrielle L. Goldberg, Odette M. Smith, Uttam K. Rao, Lindsay Dykstra, Il-Kang Na, Amanda M. Holland, Chen Liu, George F. Murphy, Warren J Leonard, Glenn Heller, PhD, Marcel R.M. van den Brink, MD, PhD

Blood (2010) 116 (21): 729.

https://doi.org/10.1182/blood.V116.21.729.729

Published: 2010

Journal Articles

Genetic Engineering of Donor T Cells for BMT Immunotherapy: Expression of TRAIL and PLZF Selectively Enhances GVT and Abrogates Gvhd

Arnab Ghosh, MD, PhD, Amanda M. Holland, BS, Yildirim Dogan, PhD, Nury Yim, BS, Uttam K. Rao, BA, Lauren F. Young, BS, Odette M. Smith, BA, Robert Jenq, MD, Il-Kang Na, MD/PhD, Jennifer Tsai, MD, Olaf Penack, MD/PhD, Alan M. Hanash, MD, PhD, Martin G. Sauer, MD, Derek Sant'Angelo, PhD, Michel Sadelain, MD, PhD, Marcel R.M. van den Brink, MD, PhD

Blood (2010) 116 (21): 730.

https://doi.org/10.1182/blood.V116.21.730.730

Published: 2010

Journal Articles

Gvhd, Hematopoietic Dysfunction, and Post-Transplant Immune Deficiency: Loss of Marrow Function Leads to Ineffective Extramedullary Hematopoiesis, However Lymphoid Reconstitution Is Restored by the Synergistic Effects of KGF, Sex Steroid Ablation, and Precursor T Cell Adoptive Therapy.

Jarrod A Dudakov, PhD, Alan M. Hanash, MD, PhD, Uttam K. Rao, Amanda M. Holland, Robert Jenq, MD, Gabrielle L. Goldberg, PhD, Richard Boyd, PhD, Marcel R.M. van den Brink, MD, PhD

Blood (2010) 116 (21): 1468.

https://doi.org/10.1182/blood.V116.21.1468.1468

Published: 2010

Journal Articles

Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo

Il-Kang Na, John C. Markley, Jennifer J. Tsai, Nury L. Yim, Bradley J. Beattie, Alexander D. Klose, Amanda M. Holland, Arnab Ghosh, Uttam K. Rao, Matthias T. Stephan, Inna Serganova, Elmer B. Santos, Renier J. Brentjens, Ronald G. Blasberg, Michel Sadelain, Marcel R. M. van den Brink

Blood (2010) 116 (11): e18–e25.

https://doi.org/10.1182/blood-2009-12-259432

Published: 2010

Includes: Supplemental data

Journal Articles

TRAIL/ DR5 Interactions Are Important for Thymic Damage After Allogeneic Bone Marrow Transplantation.

Blood (2009) 114 (22): 234.

https://doi.org/10.1182/blood.V114.22.234.234

Published: 2009

Journal Articles

Concurrent Visualization of Trafficking and NFAT Signalling in Primary T Lymphocytes and T Cell Precursors In Vivo.

Il-Kang Na, MD, John Markley, MD, PhD, Jennifer Tsai, MD, Nury L. Yim, Bradley J. Beattie, Alexander D. Klose, PhD, Amanda M. Holland, Arnab Ghosh, MD, PhD, Uttam K. Rao, Matthias Stephan, MD, PhD, Inna Serganova, PhD, Renier J. Brentjens, MD, PhD, Ron R.G. Blasberg, MD, Michel W Sadelain, MD, PhD, Marcel R.M. van den Brink, MD, PhD

Blood (2009) 114 (22): 914.

https://doi.org/10.1182/blood.V114.22.914.914

Published: 2009

Journal Articles

Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation

Blood (2009) 113 (7): 1574–1580.

https://doi.org/10.1182/blood-2008-05-155697

Published: 2009

NARROW

Bendamustine Versus Fludarabine and Cyclophosphamide for Lymphodepletion Prior to CAR-T Therapy

Reduced Insulin Sensitivity in Patients with Myeloid Malignancies and Clonal Hematopoiesis Mutations

Nrf2 regulates CD4 + T cell–induced acute graft-versus-host disease in mice

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL

Abrogation of Donor T Cell IL-21 Signaling Leads to Tissue-Specific Modulation of Immunity and Separation of Gvhd From GVL

Genetic Engineering of Donor T Cells for BMT Immunotherapy: Expression of TRAIL and PLZF Selectively Enhances GVT and Abrogates Gvhd

Gvhd, Hematopoietic Dysfunction, and Post-Transplant Immune Deficiency: Loss of Marrow Function Leads to Ineffective Extramedullary Hematopoiesis, However Lymphoid Reconstitution Is Restored by the Synergistic Effects of KGF, Sex Steroid Ablation, and Precursor T Cell Adoptive Therapy.

Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo

TRAIL/ DR5 Interactions Are Important for Thymic Damage After Allogeneic Bone Marrow Transplantation.

Concurrent Visualization of Trafficking and NFAT Signalling in Primary T Lymphocytes and T Cell Precursors In Vivo.

Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only